{
    "symbol": "GDDY",
    "quarter": 1,
    "year": 2022,
    "date": "2022-05-04 20:33:10",
    "content": " Normalized EBITDA grew 18% year-over-year to $226 million at a 23% margin, representing over a point of margin expansion compared to the same period last year and bringing our normalized EBITDA margins within the 23% to 24% guide we outlined at Investor Day. We are marching towards delivering the 10% top line CAGR, 15% normalized EBITDA CAGR and 20% or better free cash flow per share CAGR, while buying back $3 billion of our stock over the next three years, that we described in detail in our Investor Day."
}